Diabetes therapy and cancer risk: Causal effects and other plausible explanations

Diabetologia

Volumn 53, Issue 5, 2010, Pages 802-808

  Hernandez Diaz S ^a   Adami, H O ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; Insulin analogues; Insulin therapy; Metformin; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; METFORMIN; SULFONYLUREA DERIVATIVE;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CARCINOGENICITY; CAUSAL ATTRIBUTION; COLON CANCER; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; NEOPLASMS;

EID: 77952098898     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1675-2     Document Type: Note

References (14)

1. K Zendehdel O Nyrén C Ostenson H Adami A Ekbom W Ye 2003 Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden J Natl Cancer Inst 95 1797 1800 14652242 (Pubitemid 38008903)
2. H Adami J McLaughlin A Ekbom, et al. 1991 Cancer risk in patients with diabetes mellitus Cancer Causes Control 2 307 314 10.1007/BF00051670 1:STN:280:DyaK38%2Fjt1GjtA%3D%3D 1932543
3. Y Yang S Hennessy JD Lewis 2004 Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients Gastroenterology 127 1044 1050 10.1053/j.gastro.2004.07.011 1:CAS:528:DC%2BD2cXpsVOitrg%3D 15480982 (Pubitemid 39345873)
4. YW Chung 2008 Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: a case-control study in Korea Dis Colon Rectum 51 593 597 10.1007/s10350-007-9184-1 18219529
5. J Evans L Donnelly A Emslie-Smith D Alessi A Morris 2005 Metformin and reduced risk of cancer in diabetic patients BMJ 330 1304 1305 10.1136/bmj.38415.708634.F7 15849206 (Pubitemid 40813563)
6. S Bowker S Majumdar P Veugelers J Johnson 2006 Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 254 258 10.2337/diacare.29.02.06.dc05-1558 16443869 (Pubitemid 44106500)
7. CJ Currie CD Poole EAM Gale 2009 The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 1766 1777 10.1007/s00125-009-1440-6 1:CAS:528:DC%2BD1MXpsFyrsLo%3D 19572116
8. LG Hemkens U Grouven R Bender, et al. 2009 Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 1732 1744 10.1007/s00125-009-1418-4 1:CAS:528: DC%2BD1MXpsFyrsL0%3D 19565214
9. Colhoun HM, SDRN Epidemiology Group 2009 Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 1755 1765 10.1007/s00125-009-1453-1 Erratum Diabetologia 52: 2469
10. JM Jonasson R Ljung M Talbäck B Haglund S Gudbjörnsdottir G Steineck 2009 Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden Diabetologia 52 1745 1754 10.1007/s00125-009-1444-2 1:STN:280:DC%2BD1MrktlygtQ%3D%3D 19588120
11. PD Home P Lagarenne 2009 Combined randomised controlled trial experience of malignancies in studies using insulin glargine Diabetologia 52 2499 2506 10.1007/s00125-009-1530-5 1:CAS:528:DC%2BD1MXhsVWls7vK 19756478
12. A Dejgaard H Lynggaard J Råstam M Krogsgaard Thomsen 2009 No evidence of increased risk of malignancies in patients with diabetes treated with insulin determir: a meta-analysis Diabetologia 52 2507 2512 10.1007/s00125-009-1568-4 1:STN:280:DC%2BC3c%2Fjslemtw%3D%3D 19838665
13. SJ Pocock L Smeeth 2009 Insulin glargine and malignancy: an unwarranted alarm Lancet 374 511 512 10.1016/S0140-6736(09)61307-6 19616841
14. HO Adami WH Chow O Nyrén 1996 Excess risk of primary liver cancer in patients with diabetes mellitus J Natl Cancer Inst 88 1472 1477 10.1093/jnci/88.20.1472 1:STN:280:DyaK28vjvVKlsA%3D%3D 8841022 (Pubitemid 26340049)